The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: Comparative effectiveness of a time-varying treatment with competing risks

John B. Holcomb, Deborah J. Del Junco, Erin E. Fox, Charles E. Wade, Mitchell J. Cohen, Martin A. Schreiber, Louis H. Alarcon, Yu Bai, Karen J. Brasel, Eileen M. Bulger, Bryan A. Cotton, Nena Matijevic, Peter Muskat, John G. Myers, Herb A. Phelan, Christopher E. White, Jiajie Zhang, Mohammad H. Rahbar

Research output: Contribution to journalReview article

458 Scopus citations

Abstract

Objective: To relate in-hospital mortality to early transfusion of plasma and/or platelets and to time-varying plasma: red blood cell (RBC) and platelet:RBC ratios. Design: Prospective cohort study documenting the timing of transfusions during active resuscitation and patient outcomes. Data were analyzed using timedependent proportional hazards models. Setting: Ten US level I trauma centers. Patients: Adult trauma patients surviving for 30 minutes after admission who received a transfusion of at least 1 unit of RBCs within 6 hours of admission (n=1245, the original study group) and at least 3 total units (of RBCs, plasma, or platelets) within 24 hours (n=905, the analysis group). Main Outcome Measure: In-hospital mortality. Results: Plasma:RBC and platelet:RBC ratios were not constant during the first 24 hours (P<.001 for both). In a multivariable time-dependent Cox model, increased ratios of plasma:RBCs (adjusted hazard ratio= 0.31; 95% CI, 0.16-0.58) and platelets:RBCs (adjusted hazard ratio=0.55; 95% CI, 0.31-0.98) were independently associated with decreased 6-hour mortality, when hemorrhagic death predominated. In the first 6 hours, patients with ratios less than 1:2 were 3 to 4 times more likely to die than patients with ratios of 1:1 or higher. After 24 hours, plasma and platelet ratios were unassociated with mortality, when competing risks from nonhemorrhagic causes prevailed. Conclusions: Higher plasma and platelet ratios early in resuscitation were associated with decreased mortality in patients who received transfusions of at least 3 units of blood products during the first 24 hours after admission. Among survivors at 24 hours, the subsequent risk of death by day 30 was not associated with plasma or platelet ratios.

Original languageEnglish (US)
Pages (from-to)127-136
Number of pages10
JournalJAMA Surgery
Volume148
Issue number2
DOIs
StatePublished - Feb 1 2013

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: Comparative effectiveness of a time-varying treatment with competing risks'. Together they form a unique fingerprint.

  • Cite this

    Holcomb, J. B., Del Junco, D. J., Fox, E. E., Wade, C. E., Cohen, M. J., Schreiber, M. A., Alarcon, L. H., Bai, Y., Brasel, K. J., Bulger, E. M., Cotton, B. A., Matijevic, N., Muskat, P., Myers, J. G., Phelan, H. A., White, C. E., Zhang, J., & Rahbar, M. H. (2013). The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: Comparative effectiveness of a time-varying treatment with competing risks. JAMA Surgery, 148(2), 127-136. https://doi.org/10.1001/2013.jamasurg.387